MedBen Rx Blog
Fighting Pharmacy Fraud, One Claim at a Time
The Texas Attorney General’s Office recently announced the recovery of $42.7 million in taxpayer funds… the result of enforcement action against six pharmaceutical drug manufacturers alleged to have committed fraud. The companies’ violations included providing...
MedBen Rx Client Saves 39% by Tackling Specialty Drugs
With specialty drugs now making up about half of total drug spending – and poised to go even higher as more new specialty drugs roll out every year – the need for workable access solutions grows. Fortunately, MedBen Rx has them. Our unique approach incorporates a...
Transparency, Value Commitment Counter PBM Concerns
A new playbook from the National Alliance of Healthcare Purchaser Coalitions lists the top 10 concerns employer health plans have with pharmacy benefit managers (PBMs): Promoting drugs with higher prices when lower-price options are availableOffering preferred...
Download the 2023 MedBen Client Report Now!
The 2023 MedBen Client Report is now available to download from MedBen.com! In his opening note, MedBen President Kurt Harden states: “This Client Report is designed to demonstrate ways that clients can generate greater value from their health plan....
MedBen Turns 85
May 8, 2023 marks MedBen’s 85th anniversary of serving the health benefit needs of employers across the country. As such, it’s an opportune time to reflect, while also looking forward. MedBen’s growth over the decades has coincided with the evolution in group health...
Getting Down to the (MedBen) Basics
Health benefits management can be a complicated business, but that doesn’t mean it has to be. To help make things a bit more clear cut, MedBen offers dozens of MedBen Basic handouts on a variety of topics. While many of our Basics are directed at plan...
Drugmakers (Kind of) Lower Insulin Costs
Earlier this month, drug manufacturer Eli Lilly announced that it cutting the cost of two of its prescription brand insulins, Humalog and Humulin, by 70%, and capping out-of-pocket costs for privately insured patients at $35 a month. Competing...
Lower Specialty Drug Costs with MedBen Rx Access Solutions
Employers pay up to 30 times as much for specialty drugs than Medicare does, new research finds. According to the JAMA Health Forum, for the 10 most commonly used specialty drugs, employer-sponsored insurance (ESI) plans paid prices up to 3,350%...
Comparative Effectiveness Silences the Drug Ad Hype
Drug companies spend $6 billion per year on direct-to-consumer ads with the goal of getting patients to ask their doctors to prescribe drugs that, in many instances, cost substantially more but are less effective than their current medications. And with no comparative...
The 2023 MedBen University Season Starts Soon!
The 22nd Season of MedBen University (MBU) will soon be in session! In 2023, MBU will explore current benefit management issues and proven solutions MedBen offers, including: golden pen,notebook,calculator and glasses on black desk Reducing Rx spend...
Why Health Care Costs Will Rise in 2023 – and How You Can Control Them
Even though health care costs have not seen the same rate of inflation as other industries, that’s about to change. Fortunately, MedBen has a variety of inflation-hedging solutions to counter rising costs. As a recent Self-Insurer article notes, health care costs...
PBMs, GoodRx on the Legislative Hot Seat
Pharmacy benefits managers (PBMs) are increasingly being called to answer for their questionable business practices at multiple levels of government. On the state level, in recent months: A major PBM has settled with Iowa and at least 14 other states for...